Evrofarma SA (ATH: EVROF)
Greece
· Delayed Price · Currency is EUR 1.755
-0.035 (-1.96%)
Dec 20, 2024, 5:16 PM EET
Evrofarma Revenue
Evrofarma had revenue of 21.65M EUR in the half year ending June 30, 2024, with 9.90% growth. This brings the company's revenue in the last twelve months to 46.84M, down -4.88% year-over-year. In the year 2023, Evrofarma had annual revenue of 48.76M with 7.45% growth.
Revenue (ttm)
46.84M
Revenue Growth
-4.88%
P/S Ratio
0.51
Revenue / Employee
282.19K
Employees
156
Market Cap
24.00M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 48.76M | 3.38M | 7.45% |
| Dec 31, 2022 | 45.38M | 8.68M | 23.66% |
| Dec 31, 2021 | 36.70M | 2.79M | 8.23% |
| Dec 31, 2020 | 33.91M | 429.00K | 1.28% |
| Dec 31, 2019 | 33.48M | 945.00K | 2.90% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Karelia Tobacco Company Inc. | 300.53M |
| Kri-Kri Milk Industry S.A. | 247.14M |
| Papoutsanis S.A. | 69.78M |
| Loulis Food Ingredients S.A. | 200.46M |
| Eurobank Ergasias Services and Holdings S.A. | 2.84B |
| National Bank of Greece S.A. | 2.80B |